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Abstract
Background To present our intraoperative low-field mag-
netic resonance imaging (ioMRI) technique for stereotactic
brain biopsy in various intracerebral lesions.
Method Seventy-eight consecutive patients underwent
stereotactic biopsies with the PoleStar N-20/N-30 ioMRI
system and data were evaluated retrospectively. Biopsy
technique included ioMRI before surgery, followed by
insertion of the biopsy cannula in the lesion, and ioMRI
before and after biopsy. Statistical analysis was
performed to compare subgroups using Excel and SPSS
statistic software.
Results In all patients, stereotactic biopsy was possible, with
a mean intraoperative surgery time of 86.2±28.6 min and a
mean hospital stay of 11.6±4.6 days. In 97.4 % (n=76),
histology was conclusive, representing 58 brain tumors and
18 other pathologies. Five patients were biopsied previously
without conclusive diagnosis, and all biopsies were conclu-
sive this time. Mean cross-sectional lesion size in MRI T1
with contrast (n=64) was 6.9±5.7 cm2, and in lesions with-
out T1 contrast enhancement (n=14), T2 mean cross-
sectional lesion size was 5.5±3.9 cm2. Mean distance from
the cortex surface to the lesion was 3.4±1.2 cm. One patient
suffered from a postoperative wound dehiscence; neither
clinically or radiologically significant hemorrhage after sur-
gery, nor intraoperative complications occurred.
Conclusions Low-field ioMR-guided frameless stereotactic
biopsy accurately diagnosed different intracerebral lesions
without major complications for the patients, and within an
acceptable surgery time and hospital stay. In repeated non-
conclusive biopsies in particular, low-field ioMRI offers a
technique for arriving at a diagnosis.
Keywords Intracerebral lesion . Intraoperative magnetic
resonance imaging (ioMRI) . Low-field . Stereotactic brain
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Introduction
Carrying out a biopsy of intracerebral lesions has become a
standard procedure in the neurosurgical routine within the last
decades [8, 12, 18]. Accompanying major improvements in
imagingmodalities, surgical biopsy techniques have gradually
evolved over time. The first biopsies were performed free-
handed based on preoperative computed tomography (CT)
scans for planning and navigation [8, 18]. With novel
intraoperative imaging modalities such as navigation, ultra-
sound (ioUS) or magnetic resonance imaging (ioMRI) lesions
can be biopsied more precisely with intraoperative control [2,
5, 9, 10, 17]. Since stereotactic navigated biopsies do not need
additional intraoperative images, the technique is simple and
fast. However, precisionmight be limited due to intraoperative
brainshift. Intraoperative imaging techniques such as ioUS
or ioMRI are able to overcome this limitation. Neverthe-
less, ioUS needs a larger approach (craniotomy) for ade-
quate use of the probe, and its scan coverage in deep
lesions is limited. The ioMRI technique has an advantage
because lesion location (deep or superficial) does not limit
imaging quality. IoMRI is also not dependent on a certain
surgical approach for the imaging procedure, while ioUS
is [9]. Low-field ioMRI, such as PoleStar (0.15 T), was
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introduced into clinical practice within the last decade and
simplified the first open MRI techniques [2, 4, 10–13]. In
this study, we report our stereotactic brain biopsy results
using the PoleStar N-20 and N-30 to assess the benefit of
low-field ioMRI in stereotactic brain biopsies.
Materials and methods
Patient data
IoMRI (PoleStar N-20 or N-30) guided stereotactic biopsy
of different intracerebral lesions was performed in 78 pa-
tients at our department between 2006 and 2011. Mean age
of the patients was 57.5 ±18.8 years (range of 2–87y),
including 46 male (59 %) and 32 female (41 %) patients.
Patients were either positioned in supine or prone position
and all intracranial lesions were located supratentorially,
including 37 (47.4 %) in the right and 35 (44.9 %) in the
left hemisphere. Six lesions (7.7 %) were located in the
midline.
Intraoperative MRI (ioMRI) system
PoleStar N-20 (01/2006-08/2010) or N-30 (09/2010-
12/2011) (both Medtronic, Louisville, USA) were used as
the ioMRI system according to the manufacturer’s protocol.
A detailed description of the system has already been pub-
lished [12]. Briefly, the system is designed to be located
under the operating table and can be raised into imaging
position as needed during surgery. The system operates with
two vertically oriented magnetic poles (27 cm gap), with the
transmitting coils, each with a magnet field strength of
0.15 T situated on the outside of each pole.
Operative technique and trajectory guide
Under general anesthesia, the patient was positioned in
an MRI-compatible head fixation frame to allow imag-
ing of the biopsy needle during surgery. After placement
of a MRI receiving coil on the patient head, a passive
infrared reference frame was secured to the head
fixation.
Before surgery, the magnet under the operating table was
raised into imaging position to acquire preoperative images.
A 1–7 minT1 weighted sequence (T1) with contrast
(gadolinium) and/or a T2 weighted sequence (T2) were
performed in all patients to localize the intracerebral lesion.
Based on the navigation system (Medtronic), the trajectory
for the biopsy was determined. After skin incision, a stan-
dard burr hole was made and dura/pia were incised. The
base of the trajectory guide was then secured or “snapped”
in the burr hole, followed by confirmation of trajectory
using the navigation stick. The software allowed now the
calculation of the distance to the lesion. The biopsy cannula
was then placed through the trajectory guide and inserted to
the calculated depth. Successful targeting was confirmed
by a second scan. Samples were then taken from all
directions of the lesion and sent for neuropathological
examination. Before stepwise closure, another scan was
performed to rule out intraoperative complications, such
as intracerebral bleeding.
Fig. 1 A 50-year-old male
patient showed a right-sided
thalamic lesion in the
preoperative 1.5 T MRI (a
coronal, b axial and c sagittal
plane in T1 with contrast) and
the low-field 0.15 ioMRI before
biopsy (d coronal plane in T1
with contrast). IoMRI
confirmed correct location of
the cannula during biopsy (e)
and excluded intraoperative
complications after biopsy (f).
Glioblastoma was diagnosed
after pathological examination
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Statistical analysis
Descriptive statistics and non-parametric tests were used to
determine statistical significance, as appropriate. All p
values are two-sided and statistical significance was evalu-
ated at the 0.05 alpha level. All statistical analyses were
performed in SPSS (PASW) Version 20.0 (SPSS Inc., Chi-
cago, IL) and Microsoft Excel Version 14.2. Tumor lesion
size was assigned by a senior board-certified neuroradiolo-
gist and the slices of greatest cross-sectional area of the
enhanced tumor (MRI T1 sequence with contrast) or non-
enhanced tumor (MRI T2 sequence) were chosen for size
analysis.
Results
In all 78 patients, ioMRI confirmed the correct placement of
the biopsy cannula inside the intracerebral lesion before
biopsy. In two cases, however, neuropathological examina-
tion was not conclusive, showing a non-specific brain tissue
inflammation.
The conclusive 76 biopsiesmostly represented brain tumors
(n=58, 74.4 %); in more detail, 34 glioblastoma multiforme
(Fig. 1), one gliosarcoma, six anaplastic astrocytomas (WHO
Grad III), three low grade astrocytomas (WHO Grade II), nine
B-cell lymphomas (Fig. 2), three metastases, one meningioma
(WHO Grade I) and one germinoma. Histopathological exam-
ination of the remaining 18 lesions showed a brain abscess in
eight cases, two cases of HIV-associated toxoplasmosis, three
chronic demyelinating diseases, one acute demyelinating
disease, two amyloidangiopathy-associated hematomas, one
progressive multifocal leukoencephalopathy and one radiation
necrosis (Table 1).
All intracerebral lesions were located supratentorially in the
frontal (n=20), temporal (n=10), parietal (n=8) and occipital
(n=2) lobe, as well as in the corpus callosum (n=15), nucleus
Fig. 2 a 54-year-old female
patient showed a right-sided
periventricular lesion in the
preoperative 1.5 T MRI (a
coronal, b axial and c sagittal
plane in T1 with contrast) and
the low-field 0.15 ioMRI before
biopsy (d coronal plane in T1
with contrast). IoMRI
confirmed correct location of
the cannula during biopsy (e)
and excluded intraoperative
complications after biopsy (f).
B-cell lymphoma was
diagnosed after pathological
examination
Table 1 Overview of diagnosis
Diagnosis Patients (n) Percentage (%)
Brain Tumors 58 74.4
Glioblastoma Multiforme 34/58 58.6
B-Cell Lymphoma 9/58 15.6
Anaplastic Astrocytoma 6/58 10.3
Low Grad Astrocytoma 3/58 5.2
Metastasis 3/58 5.2
Gliosarkoma 1/58 1.7
Meningioma (WHO Grade I) 1/58 1.7
Germinoma 1/58 1.7
Brain Abscess 8 10.2
Chronic Demyelinating Disease 3 3.7
Toxoplasmosis 2 2.6
Amyloid Angiopathy 2 2.6
Acute Demyelinating Disease 1 1.3
Progressive Multifocal
Leukoencephalopathy
1 1.3
Radiation Necrosis 1 1.3
Non-specific Brain Tissue
Inflammation
2 2.6
Total 78 100
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caudatus (n=4), putamen (n=5), thalamus (n=13) and clivus
(n=1) (Table 2). The mean cross-sectional lesion size of the
intracerebral lesions with contrast enhancement in T1 (n=64)
was 6.9±5.7 cm2 (range 0.6–27.2 cm2). The mean cross-
sectional lesion size in lesions without contrast enhancement
(n=14) was 5.5±3.9 cm2 (range 1.5–14.8 cm2) in the T2
sequence. Mean distance of the cortex surface to the intrace-
rebral lesion was 3.4±1.2 cm (range 1.1 – 6.2 cm) (Table 3).
For 73 patients (93.5 %), the stereotactic biopsy was the
first time of biopsy. In five cases (6.5 %), a biopsy had
previously been performed. One patient received stereotactic
biopsy with ioMRI for a different lesion, four patients re-
ceived open biopsy without ioMRI for the same lesion, with-
out a conclusive result in three cases. In all of these five
patients, neurohistopathological diagnosis after ioMRI-
guided biopsy was conclusive, this time including two low
grade astrocytoma (WHO Grade II), one B-cell lymphoma,
one abscess and one chronic demyelinating disease (Table 4).
Mean intraoperative surgery time was 86.2±28.6 min
(range 35–180min) and intracerebral lesions could be detected
with contrast T1 ioMRI in 64 cases—additional T2 sequences
were useful in 14 cases. In 59 cases, the surgeon was a board-
certified neurosurgeon (attending), and in 19 cases surgery was
performed by a resident with the supervision of an attending.
Mean surgery time for the procedures performed by the attend-
ing alone was 83.8±28.8 min compared to 93.4±29.1 min
performed by a resident with the supervision of an attending
(p=0.06). Comparing stereotactic procedures performed with
the two ioMRI systems N-20 (n=54) and N-30 (n=24), mean
surgery time was comparable with 90.1±29.2 min versus 81±
27.1 min (p=0.126). Both non-conclusive biopsies were
performed with the N-20, and one patient who suffered from
impaired wound healing after biopsy was operated with the N-
30 (Table 5).
Mean duration of hospital stay was 11.6±4.6 days (range
4–21 da,ys) and immediate postoperative course was un-
eventful in 77 patients. One patient, however, suffered from
impaired wound healing in the absence of infection at post-
operative day 6, requiring surgical revision. In eight pa-
tients, the immediate postoperative CT scan showed minor,
non-space occupying hemorrhage in the area of the biopsy.
None of these patients were symptomatic and needed sec-
ond surgery.
Discussion
In this study, we present the largest study in the literature of
intraoperative low-field MR-guided frameless stereotactic
biopsy for intracerebral lesions. Our technique was safe in
all 78 cases, with neither intraoperative nor symptomatic
postoperative complications except one patient suffered
from a postoperative wound dehiscence. Biopsy led to a
diagnosis in 97.4 % (76/78) of the cases.
In general, imaging-guided techniques, and especially the
low-field MR-guided frameless stereotactic biopsy technique,
has the advantage of taking brainshift into account, ensuring
that the biopsy is taken in the area of interest and ruling out
complications such as hemorrhages at the end of the procedure
[2, 14]. Although purchase and maintenance costs are much
higher than in comparative biopsy techniques, running imag-
ing cost can be saved once the low-field MRI technique is
installed. Preoperative MR navigation sequences or postoper-
ative scans to rule out complications are not necessary, since
biopsy can be planed and navigated based on an intraoperative
low-field MR scan before surgery, and complications such as
hemorrhage can be ruled out by obtaining an intraoperative
scan after completion of the procedure. Especially in small
intracerebral lesions located in deep brain areas far away from
the brain surface, an intraoperative imaging-guided biopsy
Table 2 Localization of lesions
Localization Patients (n) Percentage (%)
Right Hemisphere 37 47.4
Left Hemisphere 35 44.9
Midline 6 7.7
Frontal 20 25.6
Temporal 10 12.8
Parietal 8 10.3
Occipital 2 2.6
Corpus Callosum 15 19.2
Thalamus 13 16.7
Putamen 5 6.4
Nucleus Caudatus 4 5.1
Clivus 1 1.3
Total 78 100
Table 3 Magnetic resonance
imaging (MRI) features Lesion Characteristics Number (n) Percentage (%) Mean Lesion Size (cm
2) SD Range
T1 with contrast
enhancement
64 82.1 6.9 5.7 0.6–27.2
T2 without T1 contrast
enhancement
14 17.9 5.5 3.9 1.5–14.8
Number (n) Mean Distance (cm) SD Range
Cortex Surface to Lesion 78 100 3.4 1.2 1.1–6.2
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technique is superior to other techniques [2]. In our study,
most of the lesions were located at a large distance from the
brain surface with a mean distance from the cortex surface to
the intracerebral lesion of 3.4 cm with an upper range of up to
6.2 cm. For these deep-located lesions, our low-field MRI
biopsy technique was able to reach the lesion using imaging
guidance.
Previously published studies using low-field MR-guided
frameless stereotactic biopsy techniques showed similar re-
sults with regards to our study. Pilot studies using
intraoperative MR-guided techniques with a range of 0.12
to 0.2 Tesla reported on biopsy diagnosis rates between 90
and 100 % [3, 6, 10, 15]. A larger study by Schulder and
Spiro using the PoleStar N-20 0.15 T system on 39 patients
showed the same diagnosis rate of 97.4 % (38/39) compared
to our study, with any intraoperative/postoperative biopsy
related mortality and morbidity [14]. Similarly to our two
cases without accurate diagnosis, the biopsy cannula in one
case in Schulder and Spiro study was confirmed to be in the
area of interest during biopsy [14]. Although not provable,
the correct location of the cannula during surgery and an
unspecific histopathological finding suggests that these le-
sions were more likely really to be unspecific inflammations
and not indicative of an inability to diagnose these lesions
using this technique.
Our histology results after biopsy were comparable to
previously published studies including mostly higher-grade
primary brain tumors and rarely chronic demyelinating dis-
eases or infections [12]. However, with regard to the location,
nearly half of our treated patients had a lesion in the corpus
callosum, thalamus or basal ganglia (Table 2). In previously
published studies lesions were more likely to be biopsied in
the frontal, temporal, parietal or occipital lobes [12, 14]. Our
mean surgery time of 1.4 h was within the range of previously
published studies. For instance, our previously published
study on biopsies using an open 0.5 T MRI was 1.2 h, and
Quinn et al. presented a mean surgery time of 1.7 h using the
Polestar N-20 MRI [2, 12]. There was also no significant
difference in surgery time between residents and attendings
as the performing surgeon in this study.
Compared to other biopsy techniques, we were able to
achieve a high histopathological diagnosis yield of 97.4 %
with our method. Tsermoulas et al. showed in a series of 124
consecutive patients with different biopsy methods such as
freehand, ultrasound guided, frameless and frame-based ste-
reotactic methods that no significant differences between the
Table 4 Patient and surgery
characteristics Patient Characteristics Number (n) Percentage (%) Age (years) SD Range
Overall 78 100 57.5 18.8 2.0–87.0
Female 32 41 53.8 19.8 2.0–87.0
Male 46 59 60.1 17.8 13.0–86.0
Biopsy Type Number (n) Percentage (%)
Primary Biopsy 73 93.5
Biopsy performed before 5 6.5
non conclusive before 3 60
conclusive diagnosis this time 5 100
Surgery features Patients (n) Percentage (%)
Hospital Stay in days (SD) 11.6 (4.6) 78 100
Surgery time in minutes (SD) 86.2 (28.6) 78 100
Intraoperative complications 0 0
Postoperative asymptomatic
hemorrhage CT scan
8 10.3
Wound Healing Complication 1 1.3
Table 5 Surgeons' education
level and ioMRI systems Patients (n) Percentage (%) Surgery time (minutes) SD
Overall 78 100 86.2 28.6
Surgeons' education level
Attending 59 75.6 83.8 28.8 p=0.06
Resident 19 24.4 93.4 29.1
ioMRI system
N-20 54 69.2 90.1 29.2 p=0.126
N-30 24 30.8 81 27.1
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methods could be detected - the total histopathological diag-
nosis rate was 93.5 % [16]. Also, other groups such as Air et
al. or Gempt et al. reported in 284 and 91 patients using
frameless stereotactic needle biopsies a diagnostic yield of
89.8 % and 93.8 %, respectively [1, 7]. Although many
different biopsy methods describe a high diagnosis rate, we
suppose that with an intraoperative imaging-based method
such as low-field MRI, the yield might be even higher, as
seen in our study. Also, with regards to repeated biopsies, we
could show that intraoperative low-fieldMR-guided frameless
stereotactic biopsy had excellent results in cases that had been
biopsied before. In our study, five patients (6.5 %) had already
been biopsied. One patient received stereotactic biopsy with
ioMRI for a different lesion, and four patients received open
biopsy without ioMRI for the same lesion without a conclu-
sive result in three cases. In all of these five patients, patho-
logical examination after ioMRI-guided biopsy was
conclusive this time. Especially in the three cases that had
not been conclusive using a different biopsy technique, this
technique was useful in arriving at a diagnosis. Therefore, in a
situation of non-conclusive biopsy, a patient might benefit
from a second biopsy using intraoperative low-field MR-
guided frameless stereotactic technique to obtain a diagnosis.
Conclusion
In this study, frameless stereotactic biopsy with a low-field
ioMRI accurately diagnosed different intracerebral lesions with
neither intraoperative nor symptomatic postoperative complica-
tions for the patients within an acceptable surgery time and
hospital stay. In repeated non-conclusive biopsies in particular,
low-field ioMRI offers a technique for arriving at a diagnosis.
Conflict of interest None.
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